Orchestra BioMed Holdings (OBIO) Change in Inventory (2022 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Change in Inventory of -$33000.0 for Q1 2026, up 13.16% year-over-year from -$29162.8 in Q1 2025, and up 40.0% quarter-over-quarter from -$55000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Change in Inventory (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Change in Inventory for 5 consecutive years, with -$33000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory rose 13.16% year-over-year to -$33000.0; the TTM figure through Mar 2026 stood at $142000.0 (up 576.19% YoY), while the FY2025 annual figure was $137000.0, up 389.29% from the prior year.
- Change in Inventory rose to -$33000.0 in Q1 2026 per OBIO's latest filing, from -$55000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $197000.0 in Q3 2022 and bottomed at -$60000.0 in Q4 2024.
- Historically, Change in Inventory has averaged $12294.1 across 5 years, with a median of -$36000.0 in 2022.
- On a YoY basis, Change in Inventory climbed as much as 500.0% in 2024 and fell as far as 850.0% in 2024.
- Orchestra BioMed Holdings' Change in Inventory stood at -$54000.0 in 2022, then jumped by 114.81% to $8000.0 in 2023, then plunged by 850.0% to -$60000.0 in 2024, then climbed by 8.33% to -$55000.0 in 2025, then jumped by 40.0% to -$33000.0 in 2026.
- Business Quant data shows OBIO's Change in Inventory at -$33000.0 in Q1 2026, -$55000.0 in Q4 2025, and $181000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Orchestra BioMed Holdings | 265.06 Mn | 80.63 Mn | 63,000.00 | -27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27,000.00 |
| Jun 30, 2026 | -27,000.00 |
| Mar 31, 2026 | -33,000.00 |
| Mar 31, 2026 | -33,000.00 |
| Dec 31, 2025 | -55,000.00 |
| Dec 31, 2025 | -55,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Jun 30, 2024 | -45,000.00 |
| Jun 30, 2024 | -45,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Mar 31, 2024 | -31,000.00 |